{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T09:52:30Z","timestamp":1782899550854,"version":"3.54.5"},"reference-count":84,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1053\/j.jvca.2019.08.025","type":"journal-article","created":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T01:43:55Z","timestamp":1566611035000},"page":"3446-3457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Review of von Willebrand Disease and Acquired von Willebrand Syndrome for Patients Undergoing Cardiac Surgery"],"prefix":"10.1053","volume":"33","author":[{"given":"Jay","family":"Berger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujatha","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Leff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2019.08.025_bib0001","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ccc.2005.04.003","article-title":"Bleeding in cardiac surgery: Its prevention and treatment \u2013 an evidence based review","volume":"21","author":"Whitlock","year":"2005","journal-title":"Crit Care Clin"},{"key":"10.1053\/j.jvca.2019.08.025_bib0002","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1055\/s-0037-1613992","article-title":"Impact, diagnosis and treatment of von Willebrand disease","volume":"84","author":"Sadler","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.jvca.2019.08.025_bib0003","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00043426-200005000-00017","article-title":"Interactions between von Willebrand Factor and Factor VIII: Where did they first meet","volume":"22","author":"Montgomery","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1053\/j.jvca.2019.08.025_bib0004","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1046\/j.1365-2516.1999.00302.x","article-title":"Hereditary pseudohaemophilia","volume":"5","author":"Von Willebrand","year":"1999","journal-title":"Haemophilia"},{"key":"10.1053\/j.jvca.2019.08.025_bib0005","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1172\/JCI106480","volume":"50","author":"Zimmermann","year":"1971","journal-title":"J Clin Invest"},{"key":"10.1053\/j.jvca.2019.08.025_bib0006","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1365-2516.2002.00672.x","article-title":"Guidelines for the diagnosis and management of von Willebrand disease in Italy","volume":"8","author":"Federici","year":"2002","journal-title":"Haemophila"},{"key":"10.1053\/j.jvca.2019.08.025_bib0007","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): Evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) expert panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"key":"10.1053\/j.jvca.2019.08.025_bib0008","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-3476(05)80384-1","article-title":"Prevalence of von Willebrand disease in children: A multiethnic study","volume":"123","author":"Werner","year":"1993","journal-title":"J Pediatr"},{"key":"10.1053\/j.jvca.2019.08.025_bib0009","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.healun.2018.03.013","article-title":"Acquired von Willebrand syndrome and impaired platelet function during venovenous extracorporeal membrane oxygenation: Rapid onset and fast recovery","volume":"37","author":"Kalbhenn","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2019.08.025_bib0010","first-page":"587","article-title":"Acquired von Willebrand syndrome in patients on long-term support with HeartMate II","volume":"51","author":"Heilmann","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2019.08.025_bib0011","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1160\/TH10-10-0634","article-title":"von Willebrand factor abnormalities in aortic valve stenosis: Pathophysiology and impact on bleeding","volume":"106","author":"Casonato","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.jvca.2019.08.025_bib0012","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood-2010-01-264507","article-title":"Endothelial von Willebrand factor regulates angiogenesis","volume":"117","author":"Starke","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.jvca.2019.08.025_bib0013","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1111\/j.1538-7836.2005.01435.x","article-title":"Pharmacokinetic studies on Willfactin, a von Willebrand factor concentrate with a low factor VIII content treated with three virus-inactivation\/removal methods","volume":"3","author":"Goudemand","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.jvca.2019.08.025_bib0014","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/jth.13551","article-title":"Von Willebrand factor and angiogenesis: Basic and applied issues","volume":"15","author":"Randi","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"11","key":"10.1053\/j.jvca.2019.08.025_bib0015","first-page":"1261","article-title":"Diagnosis and management of von Willebrand disease: Guidelines for primary care","volume":"80","author":"Yawn","year":"2009","journal-title":"Am Fam Physician"},{"issue":"Suppl 2","key":"10.1053\/j.jvca.2019.08.025_bib0016","first-page":"s3","article-title":"Role of von Willebrand factor in the haemostasis","author":"Peyvandi","year":"2011","journal-title":"Blood Transfus"},{"key":"10.1053\/j.jvca.2019.08.025_bib0017","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s40265-018-0940-4","article-title":"Andexanet Alfa: First global approval","volume":"78","author":"Heo","year":"2018","journal-title":"Drugs"},{"key":"10.1053\/j.jvca.2019.08.025_bib0018","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/jth.13294","article-title":"Aging and ABO blood type influence VWF and FVIII levels through interrelated mechanisms","volume":"14","author":"Alb\u00e1nez","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.jvca.2019.08.025_bib0019","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1111\/j.1537-2995.2010.02604.x","article-title":"Association of ABO(H) and I blood group system development with von Willebrand factor and Factor VIII plasma levels in children and adolescents","volume":"50","author":"Klarmann","year":"2010","journal-title":"Transfusion"},{"key":"10.1053\/j.jvca.2019.08.025_bib0020","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1309\/W76QF806CE80CL2T","article-title":"Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder","volume":"124","author":"Favaloro","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.jvca.2019.08.025_bib0021","doi-asserted-by":"crossref","first-page":"985","DOI":"10.4330\/wjc.v6.i9.985","article-title":"Is ABO blood group truly a risk factor for thrombosis and adverse outcomes?","volume":"6","author":"Zhou","year":"2014","journal-title":"World J Cardiol"},{"key":"10.1053\/j.jvca.2019.08.025_bib0022","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/bjh.13064","article-title":"The diagnosis and management of von Willebrand disease: A United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology","volume":"167","author":"Laffan","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1053\/j.jvca.2019.08.025_bib0023","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2796.2011.02418.x","article-title":"Von Willebrand factor predicts major bleeding and mortality during oral anticoagulant treatment","volume":"271","author":"Lind","year":"2012","journal-title":"J Intern Med"},{"key":"10.1053\/j.jvca.2019.08.025_bib0024","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1182\/blood.V76.9.1680.1680","article-title":"Bleeding complications associated with cardiopulmonary bypass","volume":"76","author":"Woodman","year":"1990","journal-title":"Blood"},{"key":"10.1053\/j.jvca.2019.08.025_bib0025","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ejcts.2007.12.047","article-title":"Non-surgical bleeding in patients with ventricular assist device could be explained by acquired von Willebrand disease","volume":"33","author":"Geisen","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2019.08.025_bib0026","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.gie.2014.03.040","article-title":"GI bleeding in patients with continuous-flow left ventricular assist devices: A systematic review and meta-analysis","volume":"80","author":"Draper","year":"2014","journal-title":"Gastrointest Endosc"},{"key":"10.1053\/j.jvca.2019.08.025_bib0027","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1055\/s-0036-1579638","article-title":"Type 2B von Willebrand disease: A matter of plasma plus platelet abnormality","volume":"42","author":"Castaman","year":"2016","journal-title":"Semin Thromb Hemost"},{"key":"10.1053\/j.jvca.2019.08.025_bib0028","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s12265-010-9222-6","article-title":"Hematologic effects of continuous flow left ventricular assist devices","volume":"3","author":"Slaughter","year":"2010","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1053\/j.jvca.2019.08.025_bib0029","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s00134-011-2370-6","article-title":"Acquired von Willebrand syndrome in patients with extracorporeal life support (ECLS)","volume":"38","author":"Heilmann","year":"2012","journal-title":"Intensive Care Med"},{"key":"10.1053\/j.jvca.2019.08.025_bib0030","first-page":"384","article-title":"Generation and optimization of the self-administered bleeding assessment tool and its validation as a screening test for von Willebrand disease","volume":"21","author":"Deforest","year":"2015","journal-title":"Haemophila"},{"key":"10.1053\/j.jvca.2019.08.025_bib0031","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1111\/j.1538-7836.2010.03975.x","article-title":"ISTH\/ SCC bleeding assessment tool: A standardized questionnaire and a proposal for a new bleeding score for the inherited bleeding disorders","volume":"8","author":"Rodeghiero","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.jvca.2019.08.025_bib0032","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/archinte.1995.00430130095010","article-title":"Usefulness of patient interview in bleeding disorders","volume":"155","author":"Sramek","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.jvca.2019.08.025_bib0033","unstructured":"National Heart, Lung, and Blood Institute. The diagnosis, evaluation, and management of von Willebrand Disease. Available at: https:\/\/www.nhlbi.nih.gov\/files\/docs\/guidelines\/vwd.pdf. Accessed October 14, 2018."},{"key":"10.1053\/j.jvca.2019.08.025_bib0034","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1182\/blood-2015-11-664680","article-title":"Rapid discrimination of the phenotypic variants of von Willebrand disease","volume":"127","author":"Roberts","year":"2016","journal-title":"Blood"},{"key":"10.1053\/j.jvca.2019.08.025_bib0035","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2141.2007.06850.x","article-title":"Differential identification of a rare form of platelet-type (pseudo-) von Willebrand disease (VWD) from Type 2B VWD using a simplified ristocetin-induced platelet agglutination mixing assay and confirmed by genetic analysis","volume":"139","author":"Favaloro","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1053\/j.jvca.2019.08.025_bib0036","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/hae.12664","article-title":"Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease","volume":"21","author":"Rydz","year":"2015","journal-title":"Haemophilia"},{"key":"10.1053\/j.jvca.2019.08.025_bib0037","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"},{"key":"10.1053\/j.jvca.2019.08.025_bib0038","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1182\/blood-2007-11-122945","article-title":"A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor","volume":"111","author":"Gallinaro","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.jvca.2019.08.025_bib0039","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1182\/blood-2008-10-165621","article-title":"von Willebrand factor to the rescue","volume":"113","author":"De Meyer","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.jvca.2019.08.025_bib0040","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMra1601561","article-title":"Von Willebrand's disease","volume":"375","author":"Leebeek","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2019.08.025_bib0041","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: A report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.jvca.2019.08.025_bib0042","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/ajh.24620","article-title":"Clinical utility of closure times using the platelet function analyzer-100\/200","volume":"92","author":"Favaloro","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1053\/j.jvca.2019.08.025_bib0043","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1046\/j.1538-7836.2003.00190.x","article-title":"Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP)","volume":"1","author":"Kaufmann","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.jvca.2019.08.025_bib0044","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2141.1981.tb02789.x","article-title":"Response of factor VIII\/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease","volume":"47","author":"Mannucci","year":"1981","journal-title":"Br J Haematol"},{"key":"10.1053\/j.jvca.2019.08.025_bib0045","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1055\/s-0038-1646050","article-title":"Intranasal and intravenous administration of desmopressin: effect on F VIII\/vWF, pharmacokinetics and reproducibility","volume":"58","author":"Lethagen","year":"1987","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.jvca.2019.08.025_bib0046","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/hae.12254","article-title":"Desmopressin (DDAVP) in the management of patients with congenital bleeding disorders","volume":"20","author":"Lessinger","year":"2014","journal-title":"Haemophilia"},{"key":"10.1053\/j.jvca.2019.08.025_bib0047","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1055\/s-0036-1581106","article-title":"Prophylaxis in von Willebrand disease: Coming of age?","volume":"42","author":"Saccullo","year":"2016","journal-title":"Semin Thromb Hemost"},{"key":"10.1053\/j.jvca.2019.08.025_bib0048","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1182\/blood.V99.1.180","article-title":"Reduced von Willebrand factor survival in type Vicenza von Willebrand disease","volume":"99","author":"Casonato","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.jvca.2019.08.025_bib0049","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0140-6736(77)91197-7","article-title":"1-Desamino-8-D-arginine vasopressin: A new pharmacological approach to the management of haemophilia and von Willebrands\u2019 diseases","volume":"1","author":"Mannucci","year":"1977","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2019.08.025_bib0050","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-2002-27814","article-title":"Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: Diagnostic and therapeutic implications","volume":"28","author":"Michiels","year":"2002","journal-title":"Semin Thromb Hemost"},{"key":"10.1053\/j.jvca.2019.08.025_bib0051","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1365-2141.1994.tb05127.x","article-title":"Biological effect of desmopressin in eight patients with type 2N (Normandy) von Willebrand disease","volume":"88","author":"Mazurier","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1053\/j.jvca.2019.08.025_bib0052","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1182\/blood-2003-06-2072","article-title":"Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: Results of a multicenter European study","volume":"103","author":"Federici","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.jvca.2019.08.025_bib0053","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1182\/blood-2007-08-109231","article-title":"Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): Results from the European Study MCMDM-1VWD","volume":"111","author":"Castaman","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.jvca.2019.08.025_bib0054","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1182\/blood.V90.7.2515","article-title":"Desmopressin (DDAVP) in the treatment of bleeding disorders: The first 20 years","volume":"90","author":"Mannucci","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.jvca.2019.08.025_bib0055","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra040403","article-title":"Treatment of von Willebrand's disease","volume":"351","author":"Mannucci","year":"2004","journal-title":"N Eng J Med"},{"key":"10.1053\/j.jvca.2019.08.025_bib0056","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-2516.2000.00367.x","article-title":"Adverse events during use of intranasal desmopressin acetate for haemophilia A and von Willebrand disease: A case report and review of 40 patients","volume":"6","author":"Dunn","year":"2000","journal-title":"Haemophilia"},{"key":"10.1053\/j.jvca.2019.08.025_bib0057","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/(SICI)1096-8652(199802)57:2<153::AID-AJH11>3.0.CO;2-D","article-title":"Antidiuretic effect of desmopressin given in hemostatic dosages to healthy volunteers","volume":"57","author":"Lethagen","year":"1998","journal-title":"Am J Hematol"},{"key":"10.1053\/j.jvca.2019.08.025_bib0058","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ajh.2830310310","article-title":"Hyponatremia and seizures in young children given DDAVP","volume":"31","author":"Smith","year":"1989","journal-title":"Am J Hematol"},{"key":"10.1053\/j.jvca.2019.08.025_bib0059","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(89)92881-X","article-title":"Desmopressin and myocardial infarction","volume":"1","author":"Lowe","year":"1989","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2019.08.025_bib0060","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1537-2995.2001.41010153.x","article-title":"The vWF content of factor VIII concentrates","volume":"41","author":"Agrawal","year":"2001","journal-title":"Transfusion"},{"key":"10.1053\/j.jvca.2019.08.025_bib0061","unstructured":"US Food and Drug Administration. Additional Standards for Human Blood and Blood products. [21 C.F.R. Sect 650.54 (Apr 2018)]."},{"key":"10.1053\/j.jvca.2019.08.025_bib0062","unstructured":"National Hemophila Foundation. MASAC Document #253, MASAC recommendations concerning products licensed for the treatment of hemophilia and other bleeding disorders (Revised April 2018). Available at: https:\/\/www.hemophilia.org\/sites\/default\/files\/document\/files\/masac253.pdf."},{"key":"10.1053\/j.jvca.2019.08.025_bib0063","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2516.2004.00893.x","article-title":"A comparative in vitro evaluation of six von Willebrand factor concentrates","volume":"10","author":"Lethagen","year":"2004","journal-title":"Haemophilia"},{"key":"10.1053\/j.jvca.2019.08.025_bib0064","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.transci.2018.10.012","article-title":"Management of acquired von Willebrand syndrome","volume":"57","author":"Charlebois","year":"2018","journal-title":"Transfus Apher Sci"},{"key":"10.1053\/j.jvca.2019.08.025_bib0065","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/bjh.14511","article-title":"Use of thromboelastography in the management of a patient with acquired von Willebrand disease undergoing cardiac bypass surgery","volume":"181","author":"Stolla","year":"2018","journal-title":"Br J Hematol"},{"key":"10.1053\/j.jvca.2019.08.025_bib0066","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2516.2012.02758.x","article-title":"Thrombotic adverse events to coagulation factor concentrates for treatment of patients with haemophilia and von Willebrand disease: A systemic review of prospective studies","volume":"18","author":"Coppola","year":"2012","journal-title":"Haemophilia"},{"key":"10.1053\/j.jvca.2019.08.025_bib0067","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1046\/j.1537-2995.1997.37897424399.x","article-title":"Hemostasis in patients with severe von Willebrand disease improves after normal platelet transfusion and normalizes with further correction of the plasma defect","volume":"37","author":"Castillo","year":"1997","journal-title":"Transfusion"},{"key":"10.1053\/j.jvca.2019.08.025_bib0068","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood.V77.9.1901.1901","article-title":"Hemostatic effect of normal platelet transfusion in severe von Willebrand disease patients","volume":"77","author":"Castillo","year":"1991","journal-title":"Blood"},{"key":"10.1053\/j.jvca.2019.08.025_bib0069","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1182\/blood-2013-01-479527","article-title":"Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: A prospective clinical trial","volume":"122","author":"Mannucci","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.jvca.2019.08.025_bib0070","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1055\/s-0030-1255445","article-title":"Structure and function of a recombinant von Willebrand factor drug candidate","volume":"36","author":"Turecek","year":"2010","journal-title":"Semin Thromb Hemost"},{"key":"10.1053\/j.jvca.2019.08.025_bib0071","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood-2015-02-629873","article-title":"Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease","volume":"126","author":"Gill","year":"2015","journal-title":"Blood"},{"key":"10.1053\/j.jvca.2019.08.025_bib0072","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-0035-1564065","article-title":"An integral approach to von Willebrand disease and surgical myocardial revascularization","volume":"4","author":"Jiritano","year":"2015","journal-title":"Thorac Cardiovasc Surg Rep"},{"key":"10.1053\/j.jvca.2019.08.025_bib0073","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1016\/j.athoracsur.2016.03.110","article-title":"Successful coronary artery bypass in Types 2M and 2N von Willebrand disease","volume":"102","author":"Fiore","year":"2016","journal-title":"Ann Thorac Surg"},{"issue":"4 Suppl","key":"10.1053\/j.jvca.2019.08.025_bib0074","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/01.pcc.0000449178.45435.a7","article-title":"Abstract 452: loss of large von Willebrand factor multimers during pediatric extracorporeal membrane oxygenation support","volume":"15","author":"Nguyen","year":"2014","journal-title":"Pediatr Crit Care Med"},{"key":"10.1053\/j.jvca.2019.08.025_bib0075","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3389\/fmed.2018.00361","article-title":"Coagulation and bleeding management in pediatric extracorporeal membrane oxygenation: Clinical scenarios and review","volume":"5","author":"Hensch","year":"2019","journal-title":"Front Med"},{"key":"10.1053\/j.jvca.2019.08.025_bib0076","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.healun.2018.03.013","article-title":"Acquired von Willebrand syndrome and impaired platelet function during venovenous extracorporeal membrane oxygenation: Rapid onset and fast recovery","volume":"37","author":"Kalbhenn","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2019.08.025_bib0077","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/CRD.0000000000000212","article-title":"Gastrointestinal bleeding during continuous-flow left ventricular assist device support: State of the field","volume":"27","author":"Kataria","year":"2019","journal-title":"Cardiol Rev"},{"key":"10.1053\/j.jvca.2019.08.025_bib0078","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1182\/blood-2015-12-635094","article-title":"How I treat patients with inherited bleeding disorders who need anticoagulant therapy","volume":"128","author":"Martin","year":"2016","journal-title":"Blood"},{"key":"10.1053\/j.jvca.2019.08.025_bib0079","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/bjh.14511","article-title":"Use of thromboelastography in the management of a patient with acquired von Willebrand disease undergoing cardiac bypass surgery","volume":"181","author":"Stolla","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1053\/j.jvca.2019.08.025_bib0080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1160\/TH16-06-0430","article-title":"Monitoring of coagulation factor therapy in patients with von Willebrand disease type 3 using a microchip flow chamber system","volume":"117","author":"Agren","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.jvca.2019.08.025_bib0081","doi-asserted-by":"crossref","first-page":"e27714","DOI":"10.1002\/pbc.27714","article-title":"Utility of thromboelastography for the diagnosis of von Willebrand disease","volume":"66","author":"Regling","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"10.1053\/j.jvca.2019.08.025_bib0082","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/bja\/aeq413","article-title":"Acquired type 2A von Willebrand syndrome caused by aortic valve disease corrects during valve surgery","volume":"106","author":"Solomon","year":"2011","journal-title":"Br J Anaesth"},{"key":"10.1053\/j.jvca.2019.08.025_bib0083","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1160\/TH12-06-0447","article-title":"Phase II prospective open-label trial of recombinant interleukin-11 in DDAVP-unresponsive von Willebrand disease and mild or moderate hemophila A","volume":"109","author":"Ragni","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.jvca.2019.08.025_bib0084","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s40265-017-0793-2","article-title":"Current and emerging options for the management of inherited von Willebrand disease","volume":"77","author":"Heijdra","year":"2017","journal-title":"Drugs"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077019308924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077019308924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T07:45:19Z","timestamp":1760946319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077019308924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":84,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S1053077019308924"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2019.08.025","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review of von Willebrand Disease and Acquired von Willebrand Syndrome for Patients Undergoing Cardiac Surgery","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2019.08.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}